Prescription Drug Regulation, Cost, and Access: Current Controversies in Context | Harvard University

Prescription Drug Regulation, Cost, and Access: Current Controversies in Context | Harvard University

Prescription drugs are among the most common health care interventions and have turned many once-fatal diseases into manageable conditions — but they have also been a growing source of controversy. Patients and physicians in the US struggle with increasing costs and express concerns about why certain conditions like Alzheimer’s disease remain without therapeutic options.

At the center of these debates lies the US Food and Drug Administration (FDA), a federal agency responsible for monitoring the prescription drug marketplace and enforcing basic rules and laws that affect how prescription drugs are discovered, developed, and sold.

In this course, we will investigate the major issues affecting the regulatory approval and evidence-based use of prescription drugs. You will understand the rules and regulations related to the pricing, marketing, and safety monitoring of approved prescription drugs and the importance of the FDA in regulating the pharmaceutical market.

Medical professionals who enroll in the verified track and successfully complete Module 2: Drug Development and Approval can earn AMA PRA Category 1 Credit™ (2 credits).


Course Page
Delivery
Online
Date
September 13, 2023 - September 11, 2024
Level
Introductory
Credit
Audit for FreeAdd a Verified Certificate for $299
Language
English